NeuroSense Reveals Receipt Of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement
Author: Benzinga Newsdesk | December 27, 2023 06:01pm
NeuroSense has 45 days from the date of the notice, or until February 5, 2024, to submit to Nasdaq a plan to regain compliance with the Minimum Equity Rule or an alternative continued listing standard. If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from the date of the notice, or until June 18, 2024, for the Company to regain compliance.
Posted In: NRSN